| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.71B | 173.90B | 187.21B | 188.59B | 172.07B | 152.20B |
| Gross Profit | 97.15B | 87.25B | 93.76B | 95.38B | 86.58B | 84.41B |
| EBITDA | 9.90B | 8.43B | 15.37B | 16.47B | 11.18B | 8.83B |
| Net Income | 11.69B | 6.99B | -8.63B | -1.64B | 1.73B | 7.03B |
Balance Sheet | ||||||
| Total Assets | 289.03B | 272.18B | 294.03B | 285.66B | 299.18B | 322.76B |
| Cash, Cash Equivalents and Short-Term Investments | 36.60B | 23.42B | 33.55B | 26.78B | 37.48B | 65.25B |
| Total Debt | 23.97B | 26.84B | 20.64B | 20.41B | 25.30B | 55.10B |
| Total Liabilities | 80.78B | 77.29B | 78.89B | 72.18B | 78.31B | 102.51B |
| Stockholders Equity | 205.31B | 191.82B | 211.83B | 210.20B | 217.99B | 217.25B |
Cash Flow | ||||||
| Free Cash Flow | 5.98B | 2.44B | 9.48B | 4.46B | 10.00B | 1.50B |
| Operating Cash Flow | 9.57B | 4.94B | 11.29B | 7.33B | 16.62B | 4.26B |
| Investing Cash Flow | 29.28B | 9.38B | 14.13B | 4.30B | -2.93B | -3.92B |
| Financing Cash Flow | -31.82B | -22.93B | -20.29B | -22.94B | -41.12B | 34.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥170.34B | 9.78 | 10.24% | 2.43% | 5.12% | 7.48% | |
77 Outperform | ¥135.65B | 14.56 | 11.70% | 3.59% | 3.84% | -1.90% | |
66 Neutral | ¥106.99B | 17.53 | 2.80% | 3.38% | -0.23% | -41.87% | |
62 Neutral | ¥76.61B | 19.03 | 18.28% | 6.12% | 6.69% | -72.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥240.52B | 39.72 | 5.31% | 2.29% | -4.81% | 182.73% | |
57 Neutral | ¥18.22B | -14.15 | ― | ― | 1.97% | -310.53% |